期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 288, 期 46, 页码 33081-33095出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M113.494922
关键词
Antibodies; Endosomes; Immunotherapy; Lysosomes; Phosphorylation; Tau; Alzheimer Disease; Autophagosomes
资金
- National Institutes of Health [NS077239, AG032611, AG020197]
Background: Tau immunotherapy is an emerging approach to treat Alzheimer disease. Results: Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau pathology. Conclusion: Receptor-mediated endocytosis and the intracellular endosome/autophagosome/lysosome system are likely involved in antibody-mediated clearance of pathological Tau. Significance: This study provides valuable insight into development of Tau immunotherapy. Aggregated Tau proteins are hallmarks of Alzheimer disease and other tauopathies. Recent studies from our group and others have demonstrated that both active and passive immunizations reduce Tau pathology and prevent cognitive decline in transgenic mice. To determine the efficacy and safety of targeting the prominent 396/404 region, we developed two novel monoclonal antibodies (mAbs) with distinct binding profiles for phospho and non-phospho epitopes. The two mAbs significantly reduced hyperphosphorylated soluble Tau in long term brain slice cultures without apparent toxicity, suggesting the therapeutic importance of targeting the 396/404 region. In mechanistic studies, we found that neurons were the primary cell type that internalized the mAbs, whereas a small amount of mAbs was taken up by microglia cells. Within neurons, the two mAbs were highly colocalized with distinct pathological Tau markers, indicating their affinity toward different stages or forms of pathological Tau. Moreover, the mAbs were largely co-localized with endosomal/lysosomal markers, and partially co-localized with autophagy pathway markers. Additionally, the Fab fragments of the mAbs were able to enter neurons, but unlike the whole antibodies, the fragments were not specifically localized in pathological neurons. In summary, our Tau mAbs were safe and efficient to clear pathological Tau in a brain slice model. Fc-receptor-mediated endocytosis and the endosome/autophagosome/lysosome system are likely to have a critical role in antibody-mediated clearance of Tau pathology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据